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Abstract  
 
Background: Pithecellobium dulce (Roxb.) Benth., Securidaca longepedunculata Fresn and Cryptolepis sanguinolenta 
(Lindl.) Schlt are three plants widely used in the Togolese traditional medicine to treat microbial infections. Some 
studies reported their antibacterial activity alone but until know there no data concerning their possible interaction with 
conventional antibiotics.  The main objective of this study was to investigate the antibacterial activity of the association 
of the crude extracts of the three plants with some conventional antibiotics. We further evaluate the antioxidant and the 
anti-inflammatory activities of the extracts on rat’s model.   
Materials and methods:The antimicrobial activity was evaluated by the broth microdilution assay and the Fractional 
inhibitory concentrations (FIC) determined by the checkerboard method. The anti-inflammatory activity was evaluated 
using the Carrageenan- induced rat paw edema model. The antioxidant activities and the phenol contents were 
determined by spectrophotometry. 
Results: The MICs of hydroethanolic extract of plants ranged from 3.125 to 100 mg/mL on Klebsiella pneumoniae 
strains. Synergistic action was observed only with the combination of Imipenem/P. dulce, imipenem/C. sanguinolenta, 
amikacin/P. dulce and amikacin/C. sanguinolenta against the ESBL negative Klebsiella pneumoniae strain. Of the 21 
associations, 15 were antagonistic on the ESBL-producing strains. The indifference effect was observed with the 
combination of the extract of Securidaca longepedunculata and the following antibiotics imipenem, amikacin, 
tetracyclin, ciprofloxacin, Cefotaxim; and Sulfametoxazol+Trimethoprim. The in vitro anti-inflammatory with 
Lipoxygenase inhibition activity was best with C. sanguinolenta extract while the in vivo paw edema model revealed 
that S. longepedunculata was the highest reducer of paw edema. In addition white blood cells count and biochemical 
parameters such as total proteins and immunoglobulins were significantly affected by the administration of plant 
extracts.  
Conclusion: This study revealed that the three plants although they may inhibit the bacterial growth by themselves, but 
there is also a possible synergistic action with the commercial antibiotics. Further investigations are needed to identify 
the active compounds and their mechanism of action. 
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Introduction 
 
The discovery of antibiotics marked the advent of a new era in the modern medicine and many lives were 
saved. Unfortunately, the inadequate use of these drugs has been accompanied by the rapid emergence of resistant 
strains (Davies and Davies, 2010). The development of resistance in microbes has become a major public health 
problem requiring considerable effort to find a solution (Barbosa and Levy, 2000; N'Guessan et al., 2007; Demain and 
Sanchez, 2009).  
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Beta-lactams remain the most common agents prescribed for the treatment of bacterial infections so they are 
the main object of resistance among Gram-negative bacteria worldwide (Shaikh et al., 2015). However, because of 
their lower cost, oral use, lesser side effects and availability in the market, their use continues unabated (Adwan et al., 
2010).Clinically, the continuous emergence of extended-spectrum beta-lactamase producing bacteria (ESBL) has 
considerably reduced the effectiveness of the antibiotic arsenal and, therefore, increased the rate of therapeutic failures 
(Bradley and Arrieta, 2001). Some previous studies pointed out Escherichia coli and Klebsiella pneumoniae as the 
leading Enterobacteriaceae producing beta-lactamase and then responsible for chronic infections (Delgado-Valverde et 
al., 2013). 
Pathogen invasion involves reactive local changes. The neighboring cells release antimicrobial agents to 
defend the host, leading to acute or chronic inflammation (Serhan et al., 2005). Acute inflammation is a short-term 
process that is characterized by the classic signs of swelling, redness, pain, heat and loss of function - due to tissue 
infiltration by plasma and leukocytes (Kumar et al., 2004). Polymorphonuclear leukocytes (PMNL) are essential innate 
immune cells that determine the resistance of the host to various bacterial and fungal infections. In the persistent state 
as infections caused by ESBLs, chronic inflammatory pathological conditions are established, and there is a continuous 
inflow of PMNLs (Porth et al., 2011). Activated PMNL may alter serum proteins by producing cytolytic enzymes, 
oxygen free radicals and inflammatory mediators that cause extensive collateral damage to host tissues (Chen et al., 
2009; Rani et al., 2013). Chronic inflammation leading to the production of reactive oxygen species and reactive 
nitrogen species may mediate diseases such as cancer, diabetes, cardiovascular, neurological and pulmonary disease 
(Reuter et al., 2010, Brooker 2011).  
During inflammatory reactions, pro-and anti-inflammatory mediators are produced. Some literature reports 
demonstrate a key regulatory role for lipoxygenases and their metabolites in many physiological processes, placing 
them at the center of many disease models (Wisastra and Dekker, 2014). Lipoxygenases are a group of oxidative 
enzymes with non-heme iron atom in their active site, involved in the regulation of inflammatory responses by 
generation of pro-inflammatory mediators known as leukotrienes or anti-inflammatory mediators known aslipoxins. 
These enzymes catalyze the insertion of oxygen in polyunsaturated fatty acids such as linoleic acid, linolenic acid and 
arachidonic acid to give hydroperoxides (Meriles et al., 2000; Azila and Don, 2012; Chedea and Jisaka, 2013). 
Lipoxygenases are widely distributed in plants, fungi and animal tissues (Alfadda and Sallam, 2012; Kye and Huh, 
2015).  
Herbal medicines are being used increasingly and plants have become the focus of intense study in terms of 
alternatives for antimicrobial resistance and inflammatory pathological challenges (Adwan et al., 2010). In Togo, 
traditional healers often use plant species such as Pithecellobium dulce (Roxb.) Benth., Securidaca longepedunculata 
Fresn and Cryptolepis sanguinolenta (Lindl.) Schlt for the treatment of inflammatory diseases, wounds, ears, malaria 
and many other health problems. The main objective of this study was to investigate the antibacterial activity of the 
association of the crude extracts of the three plants with some conventional antibiotics. We further evaluate the 
antioxidant and the anti-inflammatory activities of the extracts on rat’s model.  
 
Materials and Methods 
Plants materials and extraction 
 
The stem bark of Pithecellobium dulce (Roxb.) Benth. (Mimosaceae) was collected around the University of 
Lomé. The roots of Securidaca longepedunculata Fres. (Polygalaceae) and Cryptolepis sanguinolenta (Lindl.) Schlt- 
(Periplocaceae/Asclepiadaceae) were purchased in the herbal market “Atikpodzi” of Lomé in November 2015.The 
plant materials were botanically authenticated at the department of plant science and ecology of the University of Lomé 
(Togo) where specimens were deposited (numbers: 7521FDS/UL, 9491 FDS/UL andTG201546 respectively). Plants 
samples were dried in laboratory at room temperature reduced into powder and submitted to percolation with ethanol-
water (70:30, V/V) for 72 h. The extract was filtered through Whatman paper filter and evaporated to dryness under 
vacuum with an evaporator type Heidorph.  
 
Animals 
 
Wistar rats of both sexes weighing between 200 and 250g were provided by“Laboratoire de Microbiologie de 
Contrôle de Qualité des Denrées Alimentaires”, University of Lomé. The animals were feed with standard pellets. They 
were kept under alternative cycle of 12 hours of light and darkness(Baker et al., 1979). The Institutional Animal Ethical 
Committee approved the protocol of the study. 
 
Chemicals and media 
 
Folin Ciocalteu-reagent, NaH2PO4, Na2HPO4, sodium carbonate, aluminum trichloride (AlCl3), gallic acid and 
quercetin were purchased from Sigma-Aldrich Chemie (Steinheim, Germany)., 2,2-Dipheny-1-picrylhydrazyl (DPPH), 
trichloroacetic acid, methanol, ethyl acetate and n-butanol were supplied by Fluka Chemie (Buchs, Switzerland). 
Potassium hexacyanoferrate [K3Fe(CN)6] was from Prolabo (Paris, France); ascorbic acid and iron trichloride (FeCl3) 
were supplied by Labosi (Paris, France). All solvents and drugs used in this study were of analytical grade. All culture 
media were from BioRad or Bio Mérieux (France). Commercial antibiotics were from Bio Rad. 
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Microbial strains and culture media 
 
The study microorganisms included fifty ESBL Klebsiella pneumoniae strains and one strain of non ESBL 
Klebsiella pneumoniae isolated from pathologic specimens notably urine pus and blood at the Polyclinelle Wossinu-
Gbogbo of Lomé, following the methods in force in the center. Briefly, urine and pus samples were directly seeded on 
the Eosin methylene Bleu agar (Biorad, France). The blood samples were used to inoculate vials of blood culture 
hemoline (Bio Mérieux, France) for at least seven days to detect the bacterial growth. Afterwards, the Gram staining 
was performed on the subcultures prior to the identification with the API 20E System (Bio Mérieux, France). 
 
Susceptibility testing and detection of beta lactamases production on agar diffusion 
 
The susceptibility to antibiotics was performed by agar disk diffusion and the results interpreted following the 
recommendations of the Antimicrobial susceptibility Committee of the French Society for Microbiology (SFM, 2015). 
The categorization criteria are defined as sensitive (S), intermediate (I) and resistant (R) for each antibiotic used. 
However, all intermediate strains were considered as resistant in this study. A total of 19 antibiotics : 
Amoxicillin+clavulanate (AMC), Cefalotin (CF), Cefotaxim (CTX), ceftazidim (CAZ) trimethoprim-sulfamethoxazole 
(SXT), gentamicin (GM), nalidixic acid (NA), Tobramicin (TM), Norfloxacin (NOR), ciprofloxacin (CIP), Netilmycin 
(NET), Imipenem (IPM), cefoxitin (FOX), amikacin (FOX), Chloramphenicol (C), Kanamycin (K), Doxycyclin (DO), 
levofloxacin (LEV), Colistin (CL) were tested. 
The production of ESBL was assayed by the double disk synergy technique described by Jarlier et al. (1988). 
The Amoxicillin+clavulanic acid disk (AMC) was deposited between third generation cephalosporins (C3G)disks 
namely ceftazidime, cefotaxime or ceftriaxone at a distance of 2 to 3 cm on Muller Hinton agar plate. After 18 to 24 
hours incubation, the production of ESBL was revealed by the appearance of a characteristically inhibition zone 
between the AMC disk and those of C3G referred to as a “champagne-cork”. 
 
Determination of MICs and MBCs 
 
The minimum inhibitory concentration (MICs) and the minimum bactericidal concentration (MBCs)were 
determined using the96 wells plate broth microdilution method recommended by National Committee for Clinical and 
Laboratory Standards Institute (NCCLS, 2002). Overnight colonies from bacterial strains were suspended in 0.9% 
NaCl to 0.5 Mac Farland standards (10
8
cfu/mL). Theses suspensions were diluted with Müller Hinton broth to a final 
bacterial load of 10
5
cfu/mL in the wells, containing ranges of concentrations of antibiotics or plant extracts. Imipenem 
(IMP), amikacin (AN), chloramphenicol (C), tetracycline (TE), ciprofloxacin (CIP) and trimethoprim-sulfamethoxazole 
(SXT) were the tested antibiotics. After incubation of plates at 37°C during 24 hours, MICs were determined as the 
lowest concentration that inhibited visible bacterial growth in wells. Subculture was made from wells with no visible 
growth on nutrient agar and incubated under the same conditions to determine the MBC. This was defined as the lowest 
concentration that yielded no growth after subculturing. The ratio MBC/MIC was used to qualify the activity as 
bacteriostatic for MBC>MIC and bactericide for equal values of MIC and MBC.  
 
Fractional inhibitory concentration (FIC) 
 
Effects of combination of plants extracts with antibiotics were assessed by the checkerboard test according to 
Fankam et al. 2011on ESBL Klebsiella pneumoniae and non ESBL strains. The antibacterial combination concerned 
the MICs of each extract and “Imipenem (IPM), Chloramphenicol (C), Amikacin (AN), Tetracyclin (TE), Cefotaxim 
(CTX), Sulfamethoxazole-Trimethoprim (SXT), Ciprofloxacin (CIP). Fractional inhibitory concentration (FIC) was 
then calculated by adding the FIC values of extracts and antibiotic (FICE +FICA). FICE and FIC values correspond to 
lowest concentrations of extracts and antibiotic presenting no growth. 
 
Antioxidant activities 
DPPH radical scavenging activity 
 
The antioxidant activity of the extracts was assessed through their ability of scavenging stable radicals 2, 2-
diphenyl-1-picrylhydrazyl (DPPH). This activity was determined using the stable radical DPPH, according to the 
method described by Velazquez et al. (2003). The assay was performed in triplicate using 96 micro-well plates (Nalge 
Nunc International, NY, USA). Aliquots of serials dilutions were made from extracts solution (10 mg/mL) in methanol 
by mixing 100µL of each specimen with 200µL of DPPH (20mg/L in methanol). After 15 min of incubation in 
darkness at ambient temperature, the resultant absorbance was recorded at 517 nm with a spectrophotometer (EPOCH 
251465, Biotek instruments USA Micro well plate Reader) against a blank well with 100µL methanol and 200µL of 
DPPH. The concentrations scavenging 50% of free radicals (IC50) were determined by radicals scavenging activity 
percentage curves plotted from each extract by GraphPad Prism 6. Quercetin and Gallic acid were used as reference 
products. The percentage of absorbance inhibition was calculated according to the equation: 
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FRAP: Fire Reducing Assay Power 
 
The reducing power of extracts was determined according to method as described by Compaore et al. (2011). 
A reaction mixture consisting of 0.5 mL of extract, 1.25 mL of phosphate buffer (0.2 mol/L, pH 6.6) and 1.25 mL of 
aqueous potassium hexacyanoferrate (1%) was incubated for 30 min before the addition of TCA and centrifugation at 
3000 rpm for 10 minutes. In 96 micro-wells, the upper layer solution (125 µL) was mixed with 125 µL of H2O and 
25µL of FeCl3 fresh solution. Ascorbic acid was used to produce the calibration curve by reading the absorbencies at 
700 nm (Y = 105.90 X – 8.71; r2>0.99; P<0.0001). The iron (III) reducing activity of each sample was obtained from 2 
independent triplet determinations and expressed in mgAAE/g of extract. 
 
Deoxyribose degradation inhibitory assay 
 
 The extracts power to scavenge the hydroxyl radical was evaluated using the deoxyribose inhibition 
degradation test as described by Perjesi et al. (2011). The hydroxyl radical is produced in situ by iron sulfate which 
decomposes the hydrogen peroxide to hydroxyl radical attacking the deoxyribose (component of DNA) at 2' and causes 
the opening of the cycle with production of malonylaldéhyde. This product forms with the thiobarbituric acid a pink 
complex. 
 A mixture was prepared with the sample (100 µL, 1mg/mL) in phosphate buffer (50nM, pH 7.4), EDTA 
(100 µL, 1.04 mM), ferrous sulfate (100 µL, 100 mM); deoxyribose (100 µL, 60 mM) and hydrogen peroxide (100 µL, 
10 mM). The volume was completed to 1 mL with phosphate buffer. The mixture was incubated at 37°C for 1 hour and 
1 mL of trichloroacetic acid (15%), 1 mL of thiobarbituric acid (0.675% in 25 mMNaOH) were added and heat at 
100°C for 15 min. After cooling in an ice bath for 5 minutes, the tubes were centrifuged at 3000 rpm for 10 min, then 
the supernatant (200 µL)was introduced  into 96 micro-well plates to measure the absorbance. This was accessed at 532 
nm against a blank containing neither hydrogen peroxide nor iron sulfate. Quercetin was used as reference. The 
experiment was performed in triplicate and deoxyribose degradation inhibition was expressed as a percentage 
compared to the control without extract. 
 
Lipid peroxidation inhibitory assay 
 
 The extracts ability to inhibit lipid peroxidation using lecithin was evaluated according to the method 
described by Compaore et al. (2011). The reaction mixture contained 100 µL of sample (1mg/mL) in phosphate buffer 
(10mM, pH 7.4), 100 µL of ferrous sulphate (100mM), 100 µL of EDTA (1,04mM), 100 µL of hydrogen peroxide 
10mM and 100 µL of an opalescent suspension of lecithin (10mg/mL) in phosphate buffer and the  volume was made 
up to 1 mL with phosphate buffer. The resulting solution was incubated for an hour at 37°C before adding 1mL of acid 
(15% trichloroacetic acid and 0.675% thiobarbituric acid). The tubes were then heated to 100°C for 15min and cooled 
in an ice bath for 5 minutes. After centrifugation at 3000rpm for 10min, the absorbance was measured at 532 nm 
against a blank neither iron sulphate nor hydrogen peroxide. Quercetin was used as reference substance. 
 
Inhibition of 15-lipoxygenase (15-LOX) enzyme 
 
The principle is based on the reaction between oxygen and the unsaturated fatty acids of 1-4 diene structure. 
Linoleic acid serves as a substrate (Adebayor et al., 2015).  The 15-LOX (Sigma) was made up to a working solution of 
200 units/mL and kept on ice. Test sample or control (3.75µL in DMSO) was added to 142.5μL of 15-LOX in a 96 
micro-well plate. After 5 min incubation at room temperature, 150μL substrate solutions (10μL linoleic acid dissolved 
in 30μL ethanol, made up to 120 mL with 2M borate buffer at pH 9) were added to the solution. The absorbance was 
immediately measured at 234 nm. Zileuton was used as a positive control, while DMSO was used as the negative 
control (100% enzyme activity or no enzyme inhibition). Enzyme inhibition percentage of extract compared with 
negative control (100% enzyme activity) was calculated as follows: 
 
 
The results were expressed as IC50, i.e. concentration of the extracts and controls that resulted in 50% 15-LOX 
inhibition plotted on a graph by GraphPad Prism 6  
 
 
In vivo Anti- inflammatory activity by Carrageenan- induced rat paw edema model  
 
The method of Winter et al. (1962) was used to evaluate the anti-inflammatory activity with some minor 
modifications. Rats were randomly allocated into four groups of five. Group I served as control and received distilled 
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water. Group II of animals received indomethacin (10 mg/kg). Group III and IV were given hydroethanolic extract of S. 
longepedunculata, C. sanguinolenta andP. dulce respectively at doses of 400 and 800mg/kg, p.o. After 30min, 0.1mL 
of 1%W/V carrageenan freshly prepared in normal saline was injected into the sub plantar of left hind paw of rat. The 
paw volumes were then measured by the dislocation of water column in a plethsmometer at 0, 1, 2, 3, 4 and 5 hours 
after carrageenan injection (Olajide et al., 2000; Dosseh et al., 2014). The percentage of anti-inflammatory activity was 
calculated by using the formula below: 
 
 
 
Where: Vcontrol is the mean volume of the control group; Vtest the mean volume of the test group  
 
Blood analysis and total protein electrophoresis 
 
Group II to V were collected at the late phase of inflammation. Blood was collected by retro-orbital puncture 
in dry and EDTA tubes and was treated according to the statutorily accepted procedures in the medical laboratory 
bioassays. White cells, red cells and platelets counted were performed using hematology analter KX 21N. Total 
proteins were assayed by spectrophotometry using spectrometer Erba Chem 6. Total serum proteins electrophoresis of 
rats was carried out using the Minicap instrument and the Minicap Protein (E) 6 kit which enables the separation of 
serum proteins into five major fractions: Albumin, Alpha-1 globulin, Alpha-2 globulin, Beta globulin and Gamma 
globulin. 
 
Phytochemical investigations  
Total phenolic contents determination 
 
 The total phenols content was evaluated using Folin–Ciocalteu colorimetric assay described by Compaoré et 
al. (2011) with minor modifications. Mixture consisting of 25 µL of extracts, 125mL of Folin–Ciocalteu reagent (0.2 
mol/L) was incubated for 5 min before adding 100mL of sodium carbonate (75 g/L). After one hour incubation in dark, 
absorbance was recorded at 760 nm with microplate reader. Gallic acid was used as standard (y= 221.7x ; R
2
= 0.9996). 
The results were expressed in milligrams of Gallic Acid Equivalent for 100mg dry extract (mgEAG/100mg). 
 
Total Flavonoids Contents determination  
 
 Total Flavonoids Content was determined according to previous method described by Compaoré et al. (2011). 
One hundred microliters of sample and 100µL of AlCl3 (2%) were mixed in 96 micro-well plate and incubated for 10 
min. The absorbance was measured at 415 nm with microplate reader. The standard curve was generated with variable 
concentration of quercetin at 415 nm (y= 0.01686X + 0.05917 r
2=0.9986 p˂0.0001) and the results were expressed as 
mgQE/g of sample. 
 
The proanthocyanidin content determination 
 
 The method of acid / butanol described by Chamorro et al., (2012) was used with a slight modification to 
evaluate the proanthocyanidin. Two grams of NH4(Fe)SO4 were dissolved with 200 ml 190/10 (v/v) of 1-butanol / HCl 
mixture. In a test tube, 7 ml of the prepared solution and 200 μl of the extract at 1 mg / ml (dissolved in ethanol and 
water) were mixed. The test tubes were heated at 95 ° C for 90 minutes. After the reaction time, tubes were cooled in an 
ice bath and the absorbance of various solutions was assessed at 565 nm. The presence of proanthocyanidins was 
revealed by the red color in reaction tubes. The blank of the reaction is carried out under the same conditions without 
extract. The condensed tannins (CT) were expressed in micrograms of equivalents of Gallic Acid per milligram of dry 
matter (μgEGA/mg).The standard curve was generated with variable concentration of this compound comprised 
between 0 and 200 mg/L Y = 97,27X + 4,153 
r
2
 = 0,9949; p < 0,0001. Assays were carried out in triplicate and the results expressed as mean.  
 
Statistical Analysis 
 
The results were represented as a mean ± SEM of the indicated number of experiments. One-way analysis of 
variance (ANOVA) followed by Dennett’s test or by ANOVA by Bonferroni’s test were used to find the statistical 
differences between control and tested groups. All statistical analyses were performed using GraphPad Prisms Version 
6.1 and SYSTAT11. 
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Results 
Antibiotic susceptibility  
 
A total of 50 ESBL producing Klebsiella pneumoniae strains were tested for their susceptibility to commercial 
antibiotics. Figure 1 indicates the resistance rates for each antibiotic. Antibiotics such as AMC, CF, CTX, CAZ, SXT 
were totally inactive against all the tested strains, while IMP and CL showed 100% of inhibition. For the rest of 
antibiotics, the percentages of resistant strains were above 60%, except FOX and AN for which the rates were did not 
reach 10%.  
 
Figure 1: Antibiotic resistance pattern of the study strains 
 
Antibacterial activity of the plants extracts alone 
 
In total, 25 bacterial strains of K. pneumoniae isolated from the pathologic samples were tested with three 
extracts. Only one ESBL negative bacterial strain was used in the study, the bacterium was isolated from pus. The test 
with this strain yielded the following MBC/MIC values for the three extracts respectively: S. longepedunculata: 25/25 
(Bactericidal effect); P. dulce: 25/12.5 (Bacteriostatic effect) and C sanguinolenta: 12.5/3.12 (bacteriostatic effect). The 
remaining strains were ESBL producing bacteria. Table 1 displays the antibacterial activity of the extracts in relation 
with the source of isolation of these pathogens. According to the table, the MICs ranged between 6.25 and 100mg/mL 
while the MBCs ranged between 25 and 100 mg/mL for the susceptible strains. For other strains the MICs were above 
100 mg/mL. The extract of S. longepedunculata exerted bactericidal effect on 7 strains that recorded equal values of 
MBC and MIC of 25mg/mL. Of these strains, 4 were isolated from urine, 1 from pus and 2 from blood. For P. dulce, 
the bactericidal effect was observed at a concentration of 50mg/mL on five strains, 2 isolated from urine, 1 from pus 
and 2 from blood. Finally, bactericidal effect was observed on one strain isolated from urine with 50mg/mL of C. 
sanguinolenta extract. For the rest, the extract was bacteriostatic.   
 
Table 1: Distribution of bacterial strains in relation with the extracts MIB/MIC values and the source of isolation  
 
MIC/MBC  Number of bacterial strains 
Urines/ Pus/ Blood 
Remark 
S. longepedunculata P. dulce C. sanguinolenta 
6.25/25  1/1/0 0/0/0 1/0/0 Bacteriostatic 
12.5/25 0/1/1 0/1/0 1/1/0 Bacteriostatic 
25/25 4/1/2 0/0/0 0/0/0 Bactericidal 
25/50 0/0/0 0/1/1 1/0/0 Bacteriostatic 
25/100 1/0/0 0/0/0 0/0/0 Bacteriostatic 
50/50 0/0/0 2/1/2 1/0/0 Bactericidal 
50/100 0/1/0 1/0/1 0/2/0 Bacteriostatic 
25/ND 0/0/0 0/0/0 0/0/0 Bacteriostatic 
50/ND 1/0/1 2/1/1 0/0/0 Bacteriostatic 
100/ND 0/0/0 1/0/0 1/0/0 Bacteriostatic 
ND 5/1/3 5/2/2 7/2/7 Bacteriostatic 
 
Data in the table represent the number of strains isolated from a corresponding pathological product namely urine, pus 
ans blood. MBC: minimum bactericidal concentration expressed in mg/mL, MIC: minimum inhibitory concentration 
expressed in mg/mL. ND for MBC and MIC values above 100mg/mL. 
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Antibacterial activity of the conventional antibiotics alone 
 
The antibiotics were tested on the ESBL negative strain and on the ESBL positive strain that presented the 
highest values of MBC/MIC values with the plant extract. The results of these tests are presented in the table 2.   
According to the table the lowest values of MIC/MBC were recorded with the ESBL negative strain rather than the 
ESBL positive one. IPM, AN, TC and S. longepedunculata were bactericidal while C, CIP, SXT, CTX, PD and CS 
were bacteriostatic against the ESBL negative strain. The ESBL producing strain resisted highly to C, TE, CIP, CTX, 
SXT but IPM, AN, PD, SL were bactericidal. 
 
Table 2: Antibiotic MIC/MBC values 
Antibiotics MIC/MBC 
ESBL- Remarks ESBL+ Remarks 
IPM 0.25/0.25 Bactericidal 1/1 Bactericidal 
AN 3/3 Bactericidal 6/6 Bactericidal 
C 6/ > 12 Bacteriostatic >12/>12 ND 
TE 3/3 Bactericidal >24/>24 ND 
CIP 0.5/1 Bacteriostatic >8/>8 ND 
CTX 0.75/1.5 Bacteriostatic >24/>24 ND 
SXT 2.5/5 Bacteriostatic >20/>20 ND 
PD* 12.5/25 Bacteriostatic 50/50 Bactericidal 
SL* 25/25 Bactericidal 25/25 Bactericidal 
CS* 3.125/12.5 Bacteriostatic 50/100 Bacteriostatic 
 
MIC/MBC for antibiotics were expressed in µg/mL. *MIC/MBC for extracts were expressed in mg/mL 
IPM: Imipenem; AN: Amikacin; C: Chloramphenicol; CIP: Ciprofloxacin; TE: Tetracyclin; CTX: Cefotaxim; SXT: 
Sulfametoxazol+Trimethoprim. PD: Pithecellobium dulce. SL: Securidaca longepedunculata. CS: Cryptolepis 
sanguinolenta. ND: not determined 
 
Antibacterial activity of the associations 
 
The results of the combination of the plant extracts with antibiotics IPM, AN, C, TE, CIP, CTX, SXT and their 
isolated activity on ESBL producing Klebsiella pneumoniae strain and those of ESBL negative Klebsiella Pneumoniae 
are shown in Table 3. They were expressed as fractions of inhibitory concentrations for each antibiotic and for each 
extract. 
Synergistic action was observed only with the combination of IPM/PD, IPM/CS, AN/PD and AN/CS against 
the ESBL negative Klebsiella pneumoniae strain. The trend was different for the ESBL producing strain. Antagonism 
was observed on the two strains with the combination of all extracts and chloramphenicol as well as C. Sanguinolenta 
extract combined with cefotaxim and tetracyclin. Particularly on the BLSE positive strain of Klebsiella pneumoniae, 
the antagonistic effect was observed at several levels in addition to those already reported. Overall, there was more 
antagonism effect generated by this strain than that of the ESBL negative because of the 21 associations of extracts, 15 
were antagonists on the ESBL-producing strains. The indifference effect was observed with the combination of the 
extract of Securidaca longepedunculata and the following antibiotics IPM, AN, TE, CIP, CTX, SXT.  
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Table 3: Antibacterial activity and FIC indices Klebsiella pneumoniae MIC value recorded MICA/MICE (∑FICI)FICA+FICE) 
Combinations ESBL-  ESBL+ 
MICA/MICE FICA+FICE(∑FICI)  Remarks MICA/MICE FICA+FICE(∑FICI)  Remarks  
IPM/PD 0.25/12.5 0.125+0.25(0.375)  Synergistic 1/50 2+0.5 (2.5) Antagonism 
IPM/SL 0.25/25 0.125+1(1.125)  Indifference  1/25 1+1(2)  Indifference 
IPM/CS 0.25/3.125 0.125+0.125(0.25)  Synergistic 1/100 1+4 (5)  Antagonism 
AN/PD 3/12.5 0.5+0.25(0.75)  Synergistic 6/50 1+1(2)  Indifference 
AN/SL 3/25 1+0.5(1.5) Indifference 6/25 1+1(2)  Indifference 
AN/CS 3/3.125 0.25+0.125(0.375)  Synergistic 6/100 0.5+4(4.5) Antagonism 
C/PD 6/12.5 >4  Antagonism  >12/50 >5  Antagonism 
C/SL 6/25 >5  Antagonism >12/25 >5  Antagonism 
C/CS 6/>3.125 >5  Antagonism >12/100 >5  Antagonism 
TE/PD 3/12.5 0.5+1(1.5)  Indifference >24/50 1+1(2)  Indifference 
TE/SL 3/25 1+1(2)  Indifference >24/25 >4  Antagonism 
TE/CS 3/3.125 >5  Antagonism >24/3.125 >5  Antagonism 
CIP/PD 0.5/12.5 1+0.5 (1.5)  Indifference >8/50 1+1(2)  Indifference 
CIP/SL 0.5/25 1+1(2)  Indifference >8/25 2+1(3) Antagonism 
CIP/CS 0.5/3.125 1+1(2)  Indifference >8/100 4+2(6)  Antagonism 
CTX/PD 0.75/12.5 1+0.5 (1.5)  Indifference >24/50 >5  Antagonism 
CTX/SL 0.75/25 1+1(2)  Indifference >24/25 >5  Antagonism 
CTX/CS 0.75/3.125 2+1 (3)  Antagonism >24/100 >5  Antagonism 
SXT/PD 2.5/12.5 1+0.5 (1.5)  Indifference >20/50 1+0.5(1.5) Indifference 
SXT/SL 2.5/25 1+1 (2)  Indifference >20/25 1+2(3)  Antagonism 
SXT/CS 2.5/3.125 1+1 (2)  Indifference >20/100 >5  Antagonism 
 
FICI: Fraction Inhibition Concentration Index. ∑FICI= FICA+ FICE, FICA (MICA in combination /MICA alone) FICE (MICE in combination /MICE alone). ∑FICI˂1 sinergistic; = 1 
additive; 1 to 2 indifferent (non-interactive); > 2 antagonistic; IPM: Imipenem; AN: Amikacin; C: Chloramphenicol; CIP: Ciprofloxacin; TE: Tetracyclin; CTX: Cefotaxim; SXT: 
Sulfametoxazol+Trimethoprim. PD: Pithecellobium dulce. SL: Securidaca longepedunculata. CS: Cryptolepis sanguinolenta. E: extract; A: antibiotic; ESBL: Extended Spectrum 
Beta-Lactamase; + positive; - : negative.  
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Total phenolic, flavonoid and proanthocyanidin contents 
 
Table 4 presents the phenol contents of the extracts. The total phenolic contents were 88.93 ± 2.44, 18.06 ± 0.8 
and 13.85 ± 0.78mgGAE /100mg for P. dulce, S. longepedunculata and C. sanguinolenta, respectively. The total 
flavonoid contents were very low in the extracts, moreover, flavonoids was not detected in the extract of C. 
sanguinolenta.  The extract of P. dulce exhibited the highest concentrations in proanthocyanidins (67.44±0.80 
µgEAA/mg). The remaining extracts yielded amounts below 15 µgEAA/mg. 
 
Table4: Phenol contents of the extracts 
 
Extracts TPC (mgGAE /100mg) TFC (µgEQ/mg) TPAC (µgEAA/mg) 
P. dulce 88.93 ± 2.44 0.74 ± 0.03 67.44±0.80 
S. longepedunculata 13.85 ± 0.78 0.34 ± 0.01 9.21±0.39 
C. sanguinolenta 18.06 ± 0.8 ND 11.22±0.17 
 
µgEAA/g: µg ascorbic acid equivalents/gram; mg GAE/100mg: mg gallic acid equivalent/100gram; µgQE/mg: µg 
quercetin equivalent/milligram. TPC: Total phenolic content; TFC: Total flavonoid content; TPAC : Total 
proanthocyianidin content. ND: Non detected 
 
Antioxidant activity 
 
The antioxidant activity of the plant extracts was evaluated by several methods and the results are shown in 
Table 5. According to DPPH assay, the IC50 concentration was lower for P. dulce (11.3µg/mL) than the two other 
plants (p ˂ 0.001). Reference products as gallic acid and quercétine yielded 1.23 and 8.54 µ/mL IC50values 
respectively. The same trend was observed for the ferric reduction assay. Thus, the best power was found with P. dulce 
extract, 1.34 ± 0.03mmolAAE/g, while gallic acid, a reference compound showed 8.74 mmol AAE/g. Lypoxigenase 
IC50 were similar for P. dulce  and S. Longepedunculata . The highest value was for C. sanginolenta, about 0.47µg/mL. 
Statistically, the difference between the reference compound zileuton activity with the plants extracts was significant. 
The deoxyribose degradation and lipid peroxidation inhibition activities expressed in percentage by the three plant 
extracts and quercetin at 100µg/mL are also presented in table 5. The two inhibition percentage activities for the three 
plants ranged from 52.92 to 77.39 while quercetin as reference product exhibited very high inhibition (90.40%) 
 
Table5: Antioxidant activities 
Specimen  DPPH %IC50 
 (µg/mL) 
FRAP 
(mmolAAE/g) 
LOX %IC50 
(µg/mL) 
I%DRB I%LPO 
P. dulce 11.33 ± 1.26 1.34 ± 0.03 0.79±0.04 66.33 ± 3.31 70.95 ± 1.69 
S. longepedunculata  985.33 ± 50.36 0.06 ± 0.01 0.78±0.06 76.54 ± 2.58 60.88 ± 2.46 
C. sanguinolenta  554.67 ± 79.43 0.18 ± 0.00 0.47±0.03 77.39 ± 2.62 50.92 ± 1.91 
Quercetin 8.54 ± 0.40 5.46 ± 0.17 ND 90.40 90.02 
Gallicacid 1.23 ± 0.39 8.74 ± 0.11 ND ND ND 
Ascobicacid ND 4.20 ± 0.13 ND ND ND 
Zileuton ND ND 0.083 ND ND 
 
DPPH: 2.2-diphenyl-1- picrylhydrazyl ; FRAP: Ferric reducing antioxidant power; LOX: Lipoxigenase, I% LPO: Lipid 
peroxidation inhibition percentage; I% DRB: Deoxyribose degradation inhibition percentage. 
 
Anti-inflammatory activities 
 
The table 6 shows the inhibitory effect of the plant extracts and reference drug indomethacin on carrageenan-
induced acute paw edema in rats compared to a control group. The difference in each group was statistically significant 
(p ˂0.05) except de the second hour of treatment with carrageenan where de P value was equal to 0.061. The Maximum 
phlogistic response of carrageenan was observed at 3–5 h after the injection in the control animals. The inhibition in 
paw volumes of treated (S. longepedunculata, 400 mg/kg,p.o.) animals at 1st, 4th and 5th hours after induction of paw 
edema was significant (52.76, 59.24 and 72.25) as inindometacin treated animals (27.56, 63.04 and 67.02)at the similar 
time points. The inhibition in paw volume of treated (S. longepedunculata, 800 mg/kg, p.o.) animals at 1
st
 3
rd
 4
th
 and 5
th
 
hour after injection of paw edema were significantly (62.20, 71.76, 82.61 and 96.86) highest followed by C. 
sanguinolenta treated animals at the same dose. The acute anti-inflammatory effect of S. longepedunculata, C. 
sanguinolenta, and P. dulce from the 3
rd
 to 5
th
 hour in rats was dose dependent. P. dulce treated animals of both dose 
showed the lowest % inhibition of paw edema. 
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Table 6: Effect of plant extracts on the inhibition of left hind paw edema on carrageenan-induced inflammation in rats. 
Treatment  mg/kg Edema volume (mL) (%) 
1H* 2H 3H** 4H*** 5H*** 
Distilled water  0.32±0.07** 0.33±0.08 0.43±0.05 0.46±0.05 0.48±0.04 
Indometacin 10 0.23±0.10** 
(27.56) 
0.18±0.07 
(44.70) 
0.17±0.07* 
(60.00) 
0.17±0.07** 
(63.04) 
0.16±0.06** 
(67.02) 
P. dulce 400 0.28±0.10* 
(11.81) 
0.24±0.10 
(28.79) 
0.34±0.06* 
(21.18) 
0.30±0.07** 
(34.78) 
0.30±0.07** 
(37.70) 
800 0.26±0.04 
(18.11) 
0.30±0.01* 
(9.85) 
0.28±0.03** 
(35.29) 
0.25±0.03*** 
(46.74) 
0.20±0.02*** 
(58.12) 
S. longepedunculata 400 0.15±0.06** 
(52.76) 
0.17±0.09* 
(47.73) 
0.21±0.11** 
(50.59) 
0.19±0.09*** 
(59.24) 
0.13±0.01*** 
(72.25) 
800 0.12±0.03** 
(62.20) 
0.18±0.10* 
(44.70) 
0.12±0.04*** 
(71.76) 
0.08±0.05*** 
(82.61) 
0.01±0.00*** 
(96.86) 
C. sanguinolenta 400 0.17±0.05* 
(48.03) 
0.29±0.07* 
(11.36) 
0.30±0.06* 
(30.59) 
0.28±0.07* 
(39.67) 
0.27±0.07 
(44.50) 
800 0.13±0.07* 
(59.06) 
0.18±0.09 
(45.45) 
0.20±0.11* 
(53.53) 
0.18±0.10** 
(61.96) 
0.16±0.09** 
(67.54) 
 
Values are expressed as mean±S.E.M. (n = 4) were analyzed by one-way ANOVA followed by post hoc Dunnett’s 
test,* p< 0.05, ** P < 0.01,*** P < 0.001 when compared PD, SL, CS groups with control and each value in 
parenthesis indicates the percentage inhibition.   
 
The effects of plant extracts on hematological parameters affected by carrageenan treatment were further 
investigated. The results are presented in table 7. Globally, there was an increase of the white blood cells count (p 
˂0.05) if compared to animal group without carrageenan treatment, however a slight decrease in the cell count was 
observed in the following treated groups: C. sanguinolenta 800 mg/kg, S. longepedunculata 400mg/kg and 800mg/kg. 
No change was observed for red blood cells, hemoglobin and hematocrit amounts. The Platelets level generally 
decreased in all carrageenan treated group except in P. dulce treated animal group if compared to carrageenan free 
animal group.  
 
Table 7: Alterations in hematological parameters 
Treatment Dose Hematological and parameters 
mg/kg WBC×10
3 
(cells/mm
3
) 
RBC×10
6 
(cells/mm
3
) 
Hb (g/dL) HT (%) PT×10
4 
(cells/mm
3
) 
Carrageanan free 8.72±1.22 8.51±0.51 15.02±0.64 54.28±2.54 80.72±6.33* 
Saline 13.58±1.11 8.57±0.33 15.28±0.23 53.84±1.69 65.8±5.73* 
Indometacin 10 14.24±1.80 8.32±0.17 14.08±0.75 50.58±0.77 63.48±58.76 
P. dulce 400 14.46±0.20 8.68±0.22 14.82±0.32 53.02±1.08 70.54±3.6* 
800 16.90±1.68 8.09±0.23 14.54±0.21 50.56±0.65 80.52±5.53* 
C. sanguinolenta 400 13.80±1.05 8.65±0.29 15.35±0.44 53.05±1.20 62.6±5.39 
800 11.60±1.49 8.84±0.36 15.60±0.37 55.13±1.36 59.58±9.20* 
S. longepedunculata 400 11.08±1.08 8.91±0.27 15.85±0.34 54.85±0.85 56.43±4.91 
800 11.53±2.23 8.64±0.68 16.47±1.85 53.40±5.06 22.03±6.66* 
 
Data represented as mean ± S.E.M. (n = 4) analyzed by one way ANOVA followed by Dunnett’s post hoc test.WBC: 
white Blood Cell, RBC: Red Blood Cell, Hb: Hemoglobin, HT: Hematocrit,PT: Platelets. 
 
Table 8 displays the electrophoretic profiles of the total serum proteins of wistar rats groups undergoing 
treatments six hours after the induction of inflammation. The total protein level significantly increased for the 
indomethacin-treated group (77.37 ± 2.80 g/L) compared to the control group (69.37 ± 2.42 g/L). The same was noted 
for the albumin level of the negative control group (25.72 ± 1.47 g/L) with those of the IND, SL4 and SL8 groups 
respectively equal to 31.31 ± 1.69 g/L, 31.71 ± 1.47 g/L 31.68 ± 1.47 g/L. A statistically significant difference was also 
found between the groups treated with extracts CS8 and SL4. Alpha1 globulins were 13.03 ± 0.97 g/L and 16.11 ± 0.97 
g/L respectively for groups receiving CS8 and PD4 extracts (p <0.05). There was a difference in the albumin ratio on 
Globulins (A / G) obtained in the SL4 groups (0.81 ± 0.07) and the negative control group 0.59 ± 0.07. The alpha2 and 
beta and gamma globulin parameters were not significantly influenced by either the extracts or the reference drug. 
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Table 8: Assessment of plants extracts effect in correcting proteins involved in inflammation 
 
Electrophoretic profile 
of serum proteins (g/L) 
DW IND CS4 CS8 PD4 PD8 SL4 SL8 
Total protein 69.37±2.42 77.37±2.80* 72.82±2.42 71.67±2.42 69.80±2.42 70.81±2.42 71.47±2.42 75.32±2.42 
Albumin 25.72±1.47 31.31±1.69* 28.65±1.47 27.38±1.47 27.44±1.47 28.79±1.47 31.71±1.47* 31.68±1.47* 
α1 globulin 13.94±0.97 14.29±1.12 14.91±0.97 13.03±0.97 16.11±0.97 15.56±0.97 13.81±0.97 13.71±0.97 
α2  globulin 5.14±0.38 5.69±0.44 4.84±0.38 4.76±0.38 5.70±0.38 5.17±0.38 4.74±0.38 5.45±0.38 
β  globulin 23.40±2.92 25.30±3.38 23.18±2.92 25.66±2.92 20.12±2.92 20.79±2.92 20.39±2.92 23.88±2.92 
ɣ  globulin 1.16±0.42 0.86±0.50 1.23±0.42 0.84±0.42 0.50±0.42 0.53±0.42 0.67±0.42 0.60±0.42 
A/G Ratio 0.59±0.07 0.69±0.08 0.65±0.07 0.64±0.07 0.65±0.07 0.69±0.07 0.81±0.07
*
 0.75±0.07 
 
Data are presented as mean ± SE. DW: Distilled water; IND: Indomethacin; PD4 and PD8: Pithecellobium dulce at 400 and 800 mg/kg; CS4 and CS8: Cryptolepis sanguinolenta at 
400 and 800 mg/kg; SL4 and SL8: Securidaca longepedunculata at 400 and 800 mg/kg.  *P ˂ 0.05significant difference when compared with negative control. 
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Discussion and Conclusions 
 
Enterobacteria such as Klebsiella pneumoniae producing extended spectrum beta-lactamases are known to 
exert high resistance against third generation cephalosporins and monobactams, therefore the choice of effective and 
safe antibiotic treatment is becoming restricted. Hence, alternative agents or extracts obtained from natural medicinal 
plants need to be introduced or combined with antibiotics for therapeutic use (Stermitz et al., 2000; Ishaq et al., 2015). 
In the the fight against ESBL bacterial according to their high resistance to classic antibiotics, the chronic inflammation 
situations they caused and disorders in the metabolism in which they are sometimes involved must be took into 
account. In Togo, as in the other low income African countries, people have an old tradition of plants use for health 
care (WHO, 2014). Continuously, scientists from Togo, focus their interest in improving traditional medicine. In this 
study, we investigated the resistance profiles of ESBL producing Klebsiella pneumoniae strains to conventional 
antibiotics and determine the antibacterial activity of three plant extracts on the same strains.  
Klebsiella pneumoniae is naturally susceptible to a large number of classic antibiotics except Ampicilline 
Penicillin G, oxacillin, piperacillin ticarcilline and all macrolides. Classically according to CA-SFM and EUCAST, 
these antibiotics are not chosen to perform antibiogram unless there is a need to achieve Klebsiella specie’s 
identification. Our results showed that only Imipenem and colistin inhibited all ESBL producing Klebsiella 
pneumoniae strains of the study. ESBLs are usually plasmid mediated. Since these plasmids are easily transmitted 
among different members of the Enterobacteriaceae, accumulation of resistance genes results in strains that contain 
multiresistant plasmids. For this reason, ESBL-producing isolates are resistant to a wide variety of antibiotics (Woldu, 
2016). Moreover, the emergence of these multiply resistant Klebsiella strains is unfortunately accompanied by a 
relatively high stability of the plasmids encoding ESBLs (Podschun et al., 1998). Several explanations are possible to 
clarify resistance to inhibitors. Illiaquer (2010) revealed the presence of genes encoding for porines OmpK35 and Omp 
K36 on the membrane of Klebsiella pneumoniae multidrug resistance species that can change conformation weakening 
free movement of molecules trough these porines. Currently, the available data suggest a further increase in the 
incidence of ESBL-producing Klebsiella. As a result, the therapeutic options are becoming limited, so that in the near 
future there will be an urgent need for hospital infection control measures that counter the spread of ESBL-producing 
bacteria. Imipenem is very expensive antibiotic and colistin is not usually used due to its high toxicity. The alternative 
solution is first to test plants extract and after, to combine them to synthetic antibiotics in order to identify possible 
synergistic effects. 
According to recorded MIC and MBC values, Cryptolepis sanguinolenta hydroethanolic extract was the most 
active extract on the ESBL negative strain of Klebsiella pneumoniae. This extract also showed interesting results on the 
ESBL producing strains. Several studies from the West African subregion have reported the potency of C. 
sanguinolenta against clinical malaria (Boye et al., 1990, Bugyei et al., 2010). According to Mills-Robertson et al., 
(2012) the chloroform fraction exhibited bactericidal activity against Klebsiella pneumoniae with bacteriostatic effect. 
In our study, the inhibition rate was 8/24 (33%).  
The extract of Pithecellobium dulce exhibited antibacterial activity (15/24) about 62.5 % against ESBL 
producing Klebsiella pneumoniae strains with 66.7% of bacteriostatic effect. Pradeepa et al., (2014) studied the pulp 
extract of the plant and showed significant zone of inhibition in a dose dependent manner. The MIC and MBC values 
of the pulp extract against both Gram positive and Gram negative bacterial strains varied from 1mg to 5mg. The results 
of the study indicated that P. dulce extract showed effective inhibitory activity against Gram negative bacteria. 
Securidaca longepedunculata extract demonstrated the same rate of antibacterial activity against ESBL 
producing Klebsiella pneumoniae strains about 62.5 % with 47.67% bactericidal effect. Karou et al., (2012) showed 
that the hydroethanolic root extract of this plant exhibited MIC about 900µg/ml on Klebsiella pneumoniae CIP 52144 
ESBL negative. According to Ndamitso et al. (2013), E. coli strains were susceptible to roots aqueous extracts. The 
plant leaves extracts were more active against several Gram negative strains. 
From the three extracts, S. longepedunculata demonstrated the highest antibacterial activity and in terms of percentage 
of action, C. sanguinolenta had the lowest inhibition. The diversity observed in susceptibility of ESBL Klebsiella 
pneumoniae to extracts could be first explained by presence of capsule surrounding the bacteria as natural protection, 
porines almost damaged in its membrane which expression could extremely be modified enzymes harboring. 
Consequently, the alternative could be the investigation for possible synergistic antibacterial combinations 
capable of improving empirical prescriptions. Thus, in vitro combination of plant extracts with different antibiotics was 
investigated against ESBL producing Klebsiella pneumoniae strains. As a result, several studies (Betoni et al., 2006) 
showed that there are varied interactions between plant extracts and antibiotics. In agreement with these studies, our 
study demonstrated synergism, additivity/indifference and antagonism between antibiotics and plants extracts. There 
were synergistic effects against ESBL negative Klebsiella pneumoniae strain, but not on ESBL producing Klebsiella 
pneumoniae strain. Ishaq et al. (2015) through their work have demonstrated that Klebsiella pneumoniae strain free of 
ESBL was inhibited with synergistic effect between cefotaxim, meropenem, ofloxacin, ceftriaxone and methanolic 
extract of Adiantum capillus-veneris. Olajuyigbe, et al. (2012) studied interactions between methanolic extract of 
Acacia mearnsii and eight antibiotics. The synergistic interaction was most expressed by combining the extract with 
erythromycin, tetracycline, nalidixic acid and chloramphenicol against K. pneumoniae (ATCC 10031).  Plants 
antimicrobials have been found to be synergistic enhancers in that though they may not have any antimicrobial 
properties alone, but when they are taken concurrently with standard drugs they enhance the effect of that drug 
(Kamatou et al., 2006). 
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Chronic inflammation situation caused by infection in living systems (Spooner and Yilmaz, 2011), is the 
greatest origin of free radicals generated and they can cause extensive damage to tissues and bio-molecules leading to 
complication of disease conditions, especially degenerative diseases, and extensive lysis (Halliwell et al., 1998).Main 
examples of these are poststreptococcal glomerulonephritis, acute rheumatic fever, or Bouillaud's disease, that is a 
delayed inflammatory complication of upper respiratory tract infections by Group A β-hemolytic Streptococcus 
(McDonald et al., 2004) and Cerebritis caused by Klebsiella pneumoniae in immune competent adults without 
predisposing factors such as neurosurgery or penetrating brain injury (Majumdar et al., 2009) 
Many synthetic drugs are used to protect against oxidative damage but they have adverse side effects. Products 
are not accepted as immunological by living organisms in the same way. Some develop allergies and explained by 
hypersensitivity to it. With a patient developing an allergy to a product, the prescriber simply changes another product 
of the same pharmacological class. For these reasons among many others, it is necessary to seek and manufacture many 
molecules to frame the immune system. Another important alternative solution to the problem is to consume natural 
antioxidants from, nutraceuticals and traditional medicines (Yazdanparast et al., 2008). 
In both DPPH and FRAP test, P. dulce bark extract expressed good scavenging of free radical and ferric 
reduction capacity and largely exceeded the two other plant extracts. The reference product as Gallic acid reduced more 
radicals than quercetin. S. longepedunculata and C. sanguinolenta extract were poor in reduction of free radicals.  
According to lipid peroxidation and deoxyribose inhibition test, all plant extracts showed suitable results at 
almost the same rate with no significant statistically difference. The matter concentration did not linearly influence the 
inhibition percentage because the two results obtained from quercetin must be linked by Factor.  
Therefore, it is clear that all the three extracts have good antioxidant activities in relation with the polyphenol 
contents. Hydroxyl radicals are the major active oxygen species causing lipid peroxidation and enormous biological 
damage (Katekhaye et al., 2012). They were produced in this study by incubating ferric-EDTA with ascorbic acid and 
H2O2 at pH 7.4, and reacted with 2-deoxy-2-ribose to generate a malondialdehyde (MDA)-like product. This compound 
forms a pink chromogen upon heating with TBA at low pH (Katekhaye et al., 2012). When P. dulce, S. 
longepedunculata and C. sanguinolenta extracts were added to the reaction mixture, they removed the hydroxyl 
radicals from the sugar and prevented the reaction. According to Katekhaye et al. (2012), the total antioxidant activity 
(IC50 values) in DPPH assay by methanol and acetone P. dulce extract showed interesting results. Barku et al., (2012) 
confirmed that cryptolepine and quindoline compounds were present in the roots and in the stem of Cryptolepis 
sanguinolenta. From Akinmoladun et al. (2010) study, the reductive potential was (0.26 ± 0.00) in S. longepedunculata. 
Carrageenan-induced rat paw oedema is a suitable experimental animal model to evaluate the anti-oedematous 
effect of natural products and is believed to be biphasic (Vinegar et al., 1969). The initial first phase occurs within an 
hour of carrageenan paw edema mediated by histamine and serotonin (Kumar and Jain, 2014), while the mediators in 
the later phase are suspected to be arachidonate metabolites (prostaglandins, leukotrienes) producing an oedema 
depending on mobilization of neutrophiles (Hwang et al., 2003). Oedema induced by carrageenan after 2
rd
 hour of 
injection indicates the second phase of applying acute inflammatory model which is mediated by prostaglandins, the 
cycloxygenase products and lipoxygenase products (Vinegar et al., 1969). Non-steroidal anti-inflammatory agents 
inhibit cyclooxygenase (COX-2) enzymes involved in prostaglandin synthesis (Dosseh et al., 2014). Based on these 
reports it is possible that the inhibitory effect of the plants organs extract on carrageenan-induced inflammation in rats 
could be due to inhibition of cyclooxygenase leading to inhibition of prostaglandin synthesis. Although the 
cyclooxygenase and lipoxygenase pathways are both involved in the inflammatory process inhibitors of 
cyclooxygenase are more effective in inhibiting carrageenan-induced inflammation than lipoxygenase inhibitors 
(Shaheen et al., 2013). In our experiment, rats pre-treated with P. dulce stem bark, S. longepedunculata root bark and 
C. sanguinolenta root bark hydroethanolic extract showed a significant oedema inhibitory response after first, third and 
fifth hour following carrageenan injection. In the results of second hour, the most suitable inhibition of oedema was 
found with S. longepedunculata extract. This result suggests that all the three plant extract may act by suppressing the 
later phase of the inflammatory process by the inhibition of cyclooxygenase. So, inhibition of carrageenan induced paw 
oedema by hydroethanolic extract could be due to its inhibitory activity on the prostaglandins (Shaheen et al., 2013). 
From the three plant extracts S. longepedunculata demonstrated the highest inhibition percentage. The antinflammatory 
activity of the plant was previously described by Ojewole (2008), but the test was conducted on streptozoncin diabetic 
rats. Muanda et al., 2010 observed that S. longepedunculata extract had good anti-inflammatory properties in the in 
vitro nitrite assay by inhibiting NO production in activated macrophages. As Cryptolepine is the major alkaloid of the 
West African shrub, Cryptolepis sanguinolenta,it has been shown to inhibit nitric oxide production too.  
For many in vitro studies LOXs has been postulated to play an important role in the pathophysiology of 
several inflammatory and allergic diseases (Sacan and Turhan 2014). Lipoxygenases are lipid-peroxidizing enzymes 
involved in the biosynthesis of leukotriene from arachidonic acid, mediators of inflammatory and allergic reactions. 
These enzymes catalyze the addition of molecular oxygen to unsaturated fatty acids such as linoleic and arachidonic 
acids (Porta et al., 2002 Adebayo et al., 2015). There are four main iso-enzymes already described, namely, 5-LOX, 8-
LOX, 12-LOX and 15-LOX, depending on the site of oxidation in the unsaturated fatty acids (Porta and Rocha-Sosa, 
2002). The common substrates for LOX are linoleic and arachidonic acids. Reactive oxygen radicals (ROS) are well 
known to be produced during the inflammatory process (Trouillas et al., 2003). In this study, the three plant extracts 
showed strong LOX inhibitory activity which was best with C. sanguinolenta extract with IC50 = 0.47±0.03 µg/ml. 
Werz (2007) stated that a plant extract power inhibition of LOX depends on its quantity of polyphenols.  
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Other researchers as Yoon and Baek (2005) have shown the role of antioxidants in the inhibition of 
inflammatory enzymes such as LOX enzymes (Yoon and Baek, 2005). These assessments were in disagreement with 
our findings; hence P. dulce possessed the highest quantity of polyphenolic compounds but wasnot the strongest in 
inhibiting LOX; another molecules or process must be involved in this mechanism. The anti-inflammatory reference 
product Zileuton had IC50 of  0.083 μg/ml, about 9.39 times higher than P. dulce and S. longepedunculata, and 5.66 
times that of C. sanguinolenta. Many other plant extracts and chemical compounds have been tested for LOX inhibition 
according to Sacan and Turhan (2014) and demonstrated good IC50. Plant extracts, except garlicand grape extracts have 
inhibited LOX at a higher rate than quercetin. Celik Onar et al., (2012) have demonstrated that Epilobium 
angustofolium extract inhibited the activity of lipoxygenase; IC50 value was found as 0.57± 0.06µg/ml. Higher value of 
LOX activity IC50 = 62.6 µg/ml with the bark of F. rhynchophylla has been found according to Huh et al. (2015). 
Therefore, the selective inhibition of LOX is an important therapeutic strategy for asthma (Shah et al., 2011; Schneider 
and Bucar. 2005). Medicinal plants may therefore be potential sources of inhibitors of COX-2/LOX that may have 
fewer side effects than NSAIDs (Schneider and Bucar, 2005). Inhibitors of LOX activities could provide potential 
therapies to manage many inflammatory and allergic responses and serve as ZYFLO 600 mg cp pellic made up with 
Zileuton. 
Protein electrophoresis has been a proven diagnostic technique to examine proteins in plasma or serum in 
human (Ngure et al., 2008; Crivellente et al., 2008). The study carried out with the electrophoretic profiles has shown 
that the serum proteins concentrations of wistar rats were different, whether they received or not plants extracts. 
Through osmotic pressure, serum protein is involved in the maintenance of normal distribution of water between blood 
and tissues (Marchi et al., 2009). Several fractions of serum vary independently and widely in diseases (Crivellente et 
al., 2008). The main idea was to assess the impact of these extracts on possible changes induced on these proteins six 
hours after the inflammation induction by the carrageenan. This molecule is a mixture of sulphated polysaccharides 
extracted from red algae, gelling and immunogenic equivalent to lipopolysaccharide (LPS) (Tobacman, 2001) of the 
outer membrane of Gram-negative bacteria including Klebsiella pneumoniae (Podschun, and Ullmann, 1998). It 
disrupted the total protein level by decreasing the concentration in negative control group but indomethacin, the 
reference anti-inflammatory drug has slightly corrected the diminution significantly. All extracts have acted in the same 
way but statistically unproved. Generally the inflammatory state is marked by the increase of alpha1, alpha2-globulin 
and the decrease of gamma-globulins. The gamma globulins produced by differentiated lymphocytes, the plasmocyte 
contain the IgG, IgM, IgA, IgE, and IgD immunoglobulins (Zaias et al., 2009). These are antibodies produced by the 
organism during intrusion of foreign agent. No change was observed with gamma globulin due probably to the short 
period of inflammation installation. Plant extracts such as P. dulce at 0.4 g/kg and C. sanguinolenta at 0.8 g/kg were 
more suitable for immunomodulating than indomethacin because they have suppressed the effect induced by 
carrageenan on immunoglobulins. The potentiating of the immunosuppressive effects created was observed with the 
extract of P. dulce and S. longepedunculata at 0.8 g/kg and at a dose of 0.4 g/kg for the extracts of C. sanguinolenta 
and S. longepedunculata. 
During inflammation process, generally the number of WBC is increased at a short period of time (Porth, 
2011). This was effective because animal group treated with carrageenan had a high number of leucocytes (13.58 ± 
1.11 10
3
 cells/mm
3
) if compared to group without carrageenan (8.72 ± 1.22. 10
3
 cells/mm
3
). The corrective action we 
were looking for from plant extracts was only found with C. Sanguinolenta at dose 0.8g/kg (11.60 ± 1.49 10
3
 
cells/mm
3
) and with S. longepedunculata at doses of 0.4 and 0.8 g/kg with approximately the same value. The number 
of platelets was also very influenced by carrageenan during our experiment. Only P. dulce extract at 0.8g/kg protected 
platelets from lowering effect induced by inflammation caused by carrageenan injection. Negative effect was observed 
mainly with the S. longepedunculata extract; the mechanism is not understood. Inflammation can also affect number of 
red blood cells and haemoglobin meaning inflammatory anemia (Berger, 2007; Lee et al., 2014). That effect was not 
been observed in our study probably due to the impact delay on those parameters. Further investigations on this way 
must be performed to better understand the mechanisms.  
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